Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isopropyl Alcohol SCHEMBL28376616 | 0.90 | ALDH1A1 (0.60) | ALDH1A1LMNATSHRTDP1TP53 | |
| Isopropyl Alcohol SCHEMBL358027 | 0.90 | ALDH1A1 (0.60) | ALDH1A1LMNATSHRTDP1TP53 | |
| Isopropyl Alcohol SCHEMBL28655743 | 0.90 | ALDH1A1 (0.60) | ALDH1A1LMNATSHRTDP1TP53 | |
| Isopropyl Alcohol SCHEMBL8814180 | 0.90 | ALDH1A1 (0.60) | ALDH1A1LMNATSHRTDP1TP53 | |
| Isopropyl Alcohol SCHEMBL1807773 | 0.90 | ALDH1A1 (0.60) | ALDH1A1LMNATSHRTDP1TP53 | |
| Isopropyl Alcohol SCHEMBL6839772 | 0.90 | ALDH1A1 (0.60) | ALDH1A1LMNATSHRTDP1TP53 | |
| Isopropyl Alcohol SCHEMBL4772850 | 0.90 | — | — | |
| Isopropyl Alcohol SCHEMBL6031064 | 0.90 | ALDH1A1 (0.60) | ALDH1A1LMNATSHRTDP1TP53 | |
| Isopropyl Alcohol SCHEMBL4237313 | 0.86 | ALDH1A1 (0.55) | ALDH1A1LMNATSHRTDP1 | |
| Isopropyl Alcohol SCHEMBL1677605 | 0.86 | ALDH1A1 (0.55) | ALDH1A1LMNATSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112313775-A | Tunability of dopant concentration in thin hafnium oxide films | 应用材料公司 | 2021-02-02 | — | — | CN | claimed |
| US-20140221594-A1 | Polyurethanes Made Using Mixtures of Tertiary Amine Compounds and Lewis Acids as Catalysts | DOW GLOBAL TECHNOLOGIES LLC | 2014-08-07 | — | — | US | claimed |
| EP-2758443-A1 | POLYURETHANES MADE USING MIXTURES OF TERTIARY AMINE COMPOUNDS AND LEWIS ACIDS AS CATALYSTS | Dow Global Technologies LLC (US) | 2014-07-30 | — | — | EP | claimed |
| WO-2013043333-A1 | POLYURETHANES MADE USING MIXTURES OF TERTIARY AMINE COMPOUNDS AND LEWIS ACIDS AS CATALYSTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-03-28 | — | — | WO | claimed |
| US-20240218509-A1 | MINIMIZING RADICAL RECOMBINATION USING ALD SILICON OXIDE SURFACE COATING WITH INTERMITTENT RESTORATION PLASMA | LAM RES CORP (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240194479-A1 | METHODS AND APPLICATIONS OF NOVEL AMORPHOUS HIGH-K METAL-OXIDE DIELECTRICS BY SUPER-CYCLE ATOMIC LAYER DEPOSITION | APPLIED MATERIALS, INC. (US) | 2024-06-13 | — | — | US | disclosed |
| WO-2024059338-A2 | SELECTIVE DIRECTED ASSEMBLY-BASED PRINTING OF METAL OXIDE DIELECTRIC THIN FILMS | NORTHEASTERN UNIVERSITY (US) | 2024-03-21 | — | — | WO | disclosed |
| US-11920239-B2 | Minimizing radical recombination using ALD silicon oxide surface coating with intermittent restoration plasma | LAM RESEARCH CORPORATION (US) | 2024-03-05 | — | — | US | disclosed |
| CN-117321766-A | Method and application of novel amorphous high-K metal oxide dielectrics by supercritical atomic layer deposition | 应用材料公司 | 2023-12-29 | — | — | CN | disclosed |
| US-20230363173-A1 | METHOD OF FORMING FERROELECTRIC MEMORY DEVICE | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2023-11-09 | — | — | US | disclosed |
| WO-2023205284-A1 | LATERAL GAP FILL | LAM RESEARCH CORPORATION (US) | 2023-10-26 | — | — | WO | disclosed |
| WO-2023200072-A1 | SELECTION DEVICE, MANUFACTURING METHOD THEREFOR, AND NON-VOLATILE MEMORY DEVICE COMPRISING SELECTION DEVICE | 서울과학기술대학교 산학협력단 | 2023-10-19 | — | — | WO | disclosed |
| US-20130207053-A1 | SYNTHESIS, CAPPING AND DISPERSION OF NANOCRYSTALS | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2013-08-15 | — | — | US | disclosed |
| WO-2013043333-A1 | POLYURETHANES MADE USING MIXTURES OF TERTIARY AMINE COMPOUNDS AND LEWIS ACIDS AS CATALYSTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-03-28 | — | — | WO | disclosed |
| EP-2560916-A2 | SYNTHESIS, CAPPING AND DISPERSION OF NANOCRYSTALS | Pixelligent Technologies, LLC (US) | 2013-02-27 | — | — | EP | disclosed |
| WO-2012058271-A2 | SYNTHESIS, CAPPING AND DISPERSION OF NANOCRYSTALS | PIXELLIGENT TECHNOLOGIES, LLC (US) | 2012-05-03 | — | — | WO | disclosed |
| US-20120088845-A1 | Synthesis, capping and dispersion of nanocrystals | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2012-04-12 | — | — | US | disclosed |
| WO-2011133228-A2 | SYNTHESIS, CAPPING AND DISPERSION OF NANOCRYSTALS | PIXELLIGENT TECHNOLOGIES, LLC (US) | 2011-10-27 | — | — | WO | disclosed |
| EP-1420024-A1 | Precursor for chemical vapor deposition and thin film formation process using the same | Asahi Denka Co., Ltd. (JP) | 2004-05-19 | — | — | EP | disclosed |
| US-20040086643-A1 | Precursor for chemical vapor deposition and thin film formation process using the same | ASAHI DENKA CO., LTD. (JP) | 2004-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040086643-A1 | Precursor for chemical vapor deposition and thin film formation process using the same | RTF1, RAP1A, TIAM1 | ALDH1A1 753/4885LMNA 4335/4885TSHR 1530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.